Erica is the Vice President, Finance and Controller of Sionna. Erica has nearly 15 years of finance and operations experience. Before joining Sionna, Erica served as the Senior Director, Corporate Controller at Editas Medicine, Inc., a publicly-traded CRISPR genome editing company, where she oversaw accounting, treasury, purchasing, equity administration, accounts payable, payroll, internal controls, and tax. In addition, Erica served as the primary finance contact for SEC reporting, business development, and strategic alliances and collaborations. She began her career at Ernst & Young, where she served a variety of clients including private and public life science companies.
Erica earned a B.S. in Information Systems Audit and Control from Bentley University and M.S. in Accounting from University of Rhode Island. Erica is a licensed CPA (inactive) in Massachusetts.